Anti-CD37 antibodies for chronic lymphocytic leukemia
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.2014.890182
Reference80 articles.
1. Cancer treatment and survivorship statistics, 2012
2. Current and Emerging Treatments for Chronic Lymphocytic Leukaemia
3. Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials
4. First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
5. Chlorambucil in Indolent Chronic Lymphocytic Leukemia
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy;Cytometry Part B: Clinical Cytometry;2022-11-02
2. Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy;International Immunopharmacology;2022-08
3. CD37 in B Cell Derived Tumors—More than Just a Docking Point for Monoclonal Antibodies;International Journal of Molecular Sciences;2020-12-15
4. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia;Frontiers in Immunology;2020-11-18
5. CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia;Bioscience Reports;2020-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3